Abstract
Two iminosugars have been designed and synthesized as potential inhibitors of UDP-Galf transferase, an enzyme involved in Mycobacterium tuberculosis cell wall biosynthesis. The design is based on a proposed model of the transition state for the transferase reaction. One of the two racemic compounds is the first reported inhibitor of the target enzyme from M. smegmatis.
| Original language | English |
|---|---|
| Pages (from-to) | 2418-2420 |
| Number of pages | 3 |
| Journal | Organic and Biomolecular Chemistry |
| Volume | 2 |
| DOIs | |
| Publication status | Published - 1 Jan 2004 |